Charleston, SC -- (SBWIRE) -- 09/16/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Penn Virginia Corporation (NYSE:PVA).
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) stock plunged in the last trading session after the development stage company said that results from a trial of its most advanced experimental drug will be postponed.
Why Should Investors Buy PRAN After the Recent Fall? Just Go Here and Find Out
Prana Biotechnology completed a 6-month trial of its drug named “PBT2” back in July. The company is now expecting to reveal the results from the study in early 2014. PRAN shares opened at $4.10 on Friday, and after hitting a high price of $4.58, finally closed at $4.50. The company has a market capitalization of 183.33 million.
Penn Virginia Corporation (NYSE:PVA) shares closed higher in the previous trading session after SunTrust lifted its price objective for Penn Virginia stock from $8 per share to $9 per share in a research report written to investors on Friday.
Where PVA is Headed Exactly? Find out in This Trend Analysis Reports
Separately, Jefferies Group reaffirmed a “buy” rating on Penn Virginia shares and set a price target of $7 per share for the stock, up from its earlier price objective of $6.50 per share. PVA shares opened at $5.69 on Friday, and after touching a high price of $6.05, finally closed at $6.02.
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)